Arcutis Biotherapeutics, Inc.

Historical 13F Holders

Symbol
ARQT
CUSIP
03969K108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03969K108 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 14.1% 10/5/2026
Event 9/30/2026
Frazier Life Sciences VIII, L.P. 13D/A
7.5% 8/20/2025
Event 8/18/2025
Rubric Capital Management LP 13G/A
6.8% 2/13/2026
Event 12/31/2025
State Street Corp 13G 6.1% 11/10/2026
Event 9/30/2026
Polar Capital Holdings Plc 13G
5.3% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Prudential Financial Inc 13G/A 4.3% 5/8/2026
Event 3/31/2026
Jennison Associates LLC 13G/A 4.0% 5/6/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 297 149 M $3.96B
2026 Q2 273 131 M $3.45B
2026 Q1 273 132 M $3.12B
2025 Q4 287 129 M $3.75B
2025 Q3 242 126 M $2.37B
2025 Q2 232 127 M $1.78B
2025 Q1 244 126 M $1.97B
2024 Q4 211 129 M $1.79B
2024 Q3 190 129 M $1.20B
2024 Q2 190 127 M $1.18B
2024 Q1 169 125 M $1.24B
2023 Q4 135 101 M $327M
2023 Q3 137 67.1 M $357M
2023 Q2 142 71.8 M $684M
2023 Q1 147 71.6 M $797M
2022 Q4 145 66.1 M $980M
2022 Q3 142 59.4 M $1.13B
2022 Q2 118 49.1 M $1.05B
2022 Q1 111 48.3 M $930M
2021 Q4 95 46.4 M $962M
2021 Q3 104 45.7 M $1.09B
2021 Q2 104 45.5 M $1.24B
2021 Q1 96 46.8 M $1.35B
2020 Q4 79 41.0 M $1.15B
2020 Q3 64 34.8 M $1.02B
2020 Q2 57 33.8 M $1.02B
2020 Q1 51 32.7 M $974M